NCT05250037View on ClinicalTrials.gov

The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation (The RV-BOS Study)

RecruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

March 30, 2022

Primary Completion Date

December 31, 2027

Study Completion Date

June 30, 2028

Conditions
Bronchiolitis Obliterans SyndromeHematopoietic and Lymphoid Cell Neoplasm
Interventions
PROCEDURE

Home spirometry

Undergo spirometry measurements

PROCEDURE

Biospecimen Collection

Undergo nasal and/or oral swabs, and blood collection

OTHER

Questionnaire Administration

Complete questionnaires

Trial Locations (4)

48109

RECRUITING

University of Michigan Cancer Center, Ann Arbor

77030

RECRUITING

MD Anderson Cancer Center, Houston

94304

RECRUITING

Stanford Cancer Institute, Palo Alto

98109

RECRUITING

Fred Hutch/University of Washington Cancer Consortium, Seattle

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER